Industry News
Adequan® i.m. Shortage Expected
Due to renovations at Luitpold Pharmaceuticals Inc.'s Shirley, N.Y.-based factory, supplies of Adequan® i.m., the only polysulfated glycosaminoglycan (PSGAG) approved by the Food and Drug Administration (FDA), are expected to be limited over the coming months.
